Newron News
Most Popular Newron Story
Newron opens door to pain pact with trial launch
Switzerland's Newron Pharmaceuticals has launched a mid- to late-stage trial for its lower back pain drug ralfinamide. And analysts note that the trial launch positions Newron to ink a significant... Read more...
Latest Headlines
- December 23, 2008
- December 3, 2008
- February 11, 2008
- August 22, 2007
- July 2, 2007
- December 7, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
